A high-level overview of Pacira BioSciences, Inc. (PCRX) stock. View (PCRX) real-time stock price, chart, news, analysis, analyst reviews and more.
We take the underlying stock price, the break even point (target price), the days to expiration, and the 52-week historical volatility, and then use those figures in this formula. Depending on the strategy, we use the above or below probability (i.e., the probability the price crosses th...
The Allegations:Robbins LLP is Investigating Allegations that Pacira BioSciences, Inc. (PCRX) Failed to Disclose its Lack of Patent Protection for Exparel According to the complaint, during the class period, defendants created ...
A golden cross is the opposite of a death cross, another technical event that indicates bearish price movement may be on the horizon. Over the past four weeks, PCRX has gained 42.4%. The company currently sits at a #3 (Hold) on the Zacks Rank, also indicating that the stock could be ...
Based on 10 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $46.44, reflecting a -19.3% downside. Three different firms, including BMO Capital and Merrill Lynch, currently also have a Sell rating on the stock. ...
PCRX | Complete Pacira BioSciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Pacira BioSciences Inc. Annual stock financials by MarketWatch. View the latest PCRX financial statements, income statements and financial ratios.